Skip to main content
. 2022 Mar 29;15(4):414. doi: 10.3390/ph15040414

Table 5.

Binding energy and interactions of control drugs.

Target Protein Control Drug PubChem ID Binding Energy RMSD
TNFalpha Thalidomide 5426 −6.9 1.3
MAPK3 Minocycline 54675783 −6.7 1.9
AKT1 Resveratrol 445154 −5.9 1.8
MAPK1 Ulixertinib 11719003 −6.2 3.48